Antipsychotic and cognitive enhancer; Dopamine D1 and D2 receptor modulator

Natural inhibitor of Musashi family of RNA-binding proteins

Agonist of the GnRH receptor, inducing the secretion of the gonadotropins follicle-stimulating hormone and luteinizing hormone from the pituitary gland and to increase sex hormone production by the gonads

Dual Glycolate Oxidase/Lactate Dehydrogenase A (GO/LDHA) Inhibitor for Primary Hyperoxaluria

Novel potent GNMT inducer, inhibiting Huh7 cell growth in vitro and xenograft in vivo

Novel inhibitor of Gram-negative lipoprotein trafficking

Natural highly potent HIV latency-reversing agent

Dose dependent up-regulator of the level of E-cadherin in SW620 cells

Novel inhibitor of Plasmodium falciparum, killing both blood- and sexual-stage P. falciparum parasites

Novel Inhibitor of EGF-EGFR Interactions

Novel potent aryl hydrocarbon receptor (AHR) antagonist with the capacity to inhibit both DRE-dependent and -independent activity

Novel selective CHK1 inhibitor

Novel GluN2A-selective NMDA receptor positive allosteric modulator (PAM)

Negative control for GNE-2256

Novel inhibitor of nicotinamide phosphoribosyl transferase (NAMPT)

Novel NMDAR PAM with both an improved pharmacokinetic profile and increased selectivity against AMPARs

Novel GluN2A-selective NMDA receptor positive allosteric modulator (PAM)

Novel Met inhibitor

Novel potent and selective RORc inverse agonist

Novel GluN2A subunit-selective and brain-penetrant positive allosteric modulator (PAM) of The N-methyl-d-aspartate receptor (NMDAR)

Novel Tubulin Polymerization Inhibitor

Negative control for GMB-805

Novel potent BCR-Abl PROTAC, inducing degradation and demonstrating in vivo activity

Selective modulator of gamma-aminobutyric acid(A) receptors

Novel GM3 derivative, showing excellent migration and invasion inhibitory effects in cells and marked antitumor activity in C57BL/6 mice, involving focal adhesion and ECM-receptor interaction signaling pathways

Metabolite of soy isoflavones, promoting the proliferation of bone marrow stromal cells and osteoblasts and suppresses bone turnover

Novel glucose transporter (GLUT) inhibitor, exhibited high antitumor potency through the suppression of glucose uptake (IC 50 : 2.5 μM), while not cytotoxic to prostate and mammary epithelial cells

Glucose transporter inhibitor linker for insulin conjugate

Selective inhibitor of human glucose transporter subtype 1/4 (hGLUT1/4)

Selective inhibitor of human glucose transporter subtype 1/4 (hGLUT1/4)